The effect of raloxifene on cognitive function in postmenopausal women: a randomized clinical trial. Journal Article uri icon



  • To determine whether treatment with raloxifene has a beneficial effect on cognitive function in postmenopausal women, 50 postmenopausal women were randomized to receive raloxifene 60 mg, or placebo, for eight weeks. Participants completed pre- and post-treatment assessment of cognitive and psychological function including the Beck Anxiety and Beck Depression inventories, the SF-36 Scale of physical and emotional well-being, five tests of cognitive function including Block Design and Digit Span subtests of the Wechsler Adult Intelligence Scale-III (WAIS-III), the Logical Memory and Paired Associates subtests of the Wechsler Memory Scale-III, and the Digit Cancellation test. Results showed no significant effect attributable to eight weeks of treatment with raloxifene on cognitive, psychological, or health variables.

publication date

  • January 1, 2004

has subject area

Date in CU Experts

  • October 30, 2013 3:09 AM

Full Author List

  • Haskell SG; Richardson ED

author count

  • 2

Other Profiles

International Standard Serial Number (ISSN)

  • 0010-6178

Additional Document Info

start page

  • 355

end page

  • 358


  • 68


  • 6